| Schedule of Cash, Cash Equivalents and Marketable Investment Securities |
The
following table shows the Company’s cash, cash equivalents, and marketable investment securities by significant investment category:
Schedule of Cash, Cash Equivalents and Marketable Investment Securities
| | |
June 30, 2026 | |
| | |
Adjusted Cost | | |
Total Unrealized
Gains / (Losses) | | |
Fair Value | | |
Cash and Cash Equivalents | | |
Marketable Investment Securities | |
| Cash | |
$ | 3,649,632 | | |
$ | - | | |
$ | 3,649,632 | | |
$ | 3,649,632 | | |
$ | - | |
| Total | |
$ | 3,649,632 | | |
$ | - | | |
$ | 3,649,632 | | |
$ | 3,649,632 | | |
$ | - | |
| | |
December 31, 2025 | |
| | |
Adjusted Cost | | |
Total Unrealized
Gains / (Losses) | | |
Fair Value | | |
Cash and Cash Equivalents | | |
Marketable Investment Securities | |
| Cash | |
$ | 11,884,607 | | |
$ | - | | |
$ | 11,884,607 | | |
$ | 11,884,607 | | |
$ | - | |
| Total | |
$ | 11,884,607 | | |
$ | - | | |
$ | 11,884,607 | | |
$ | 11,884,607 | | |
$ | - | |
|